drugset / Trial / NCT01129336
Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate zoledronic acid's anti-cancer effects and Circulating Tumor Cell (CTCs) measurements in patients with HER2-negative metastatic breast cancer without bone metastasis.
Timeline
- Start
- 2010-06
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 4 mg | Intravenous |